logo
Select company
Select metric
$ 232.68MInvested Capital
VS
Market
35
Sector
60
Industry
69
History
90
$ 5.51Close
$ 3.42 - $ 7.44 52-Week Range
Ticker Information

Ticker

MNKD

Company Name

MANNKIND CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MANNKIND CORP - Invested Capital Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MNKD - Inv. Capital Historical data
DateTotal DebtShareholders EquityInvested Capital
6/30/2025$ 287.72M$ -55.04M$ 232.68M
3/31/2025$ 288.46M$ -58.62M$ 229.84M
12/31/2024$ 289M$ -78.82M$ 210.18M
9/30/2024$ 481.42M$ -209.93M$ 271.5M
6/30/2024$ 470.43M$ -225.78M$ 244.65M
3/31/2024$ 509.29M$ -229.97M$ 279.32M
12/31/2023$ 512.81M$ -246.17M$ 266.64M
9/30/2023$ 381.65M$ -251.78M$ 129.87M
6/30/2023$ 383.16M$ -260.49M$ 122.67M
3/31/2023$ 382.91M$ -255.4M$ 127.51M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MANNKIND CORP's latest trailing twelve months (TTM) Inv. Capital stands at $ -63.07M.
  • Over the past 5 years, MANNKIND CORP's average Inv. Capital has been $ 154.55M.
  • The median Inv. Capital for MANNKIND CORP during this period was $ 149.16M
  • MANNKIND CORP reached its highest Inv. Capital over the past 5 years at $ 279.32M.
  • The lowest Inv. Capital recorded by MANNKIND CORP in the same timeframe $ -63.07M

MANNKIND CORP's Inv. Capital vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Inv. Capital Benchmarks
CompanyInv. Capital
RCUS : ARCUS BIOSCIENCES INC $ 646MXERS : XERIS BIOPHARMA HOLDINGS INC $ 237.92MAUPH : AURINIA PHARMACEUTICALS INC $ 417.13MARDX : ARDELYX INC $ 346.17MMDXG : MIMEDX GROUP INC $ 235.09MIOVA : IOVANCE BIOTHERAPEUTICS INC $ 751.65MINVA : INNOVIVA INC $ 1.16BDNA : GINKGO BIOWORKS HOLDINGS INC $ 1.04BTVTX : TRAVERE THERAPEUTICS INC $ 432.32MAKBA : AKEBIA THERAPEUTICS INC $ 76.96M

Definition of Invested Capital

[Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
Debt + Equity
(=) Inv. Capital
Inv. Capital for MANNKIND CORP is calculated as follows: Debt [ $ 123.35M ] + Equity [ $ -186.42M ]
(=) Inv. Capital [ $ -63.07M ]

MNKD - Invested Capital, Last 5 years

$ -63.07M

Minimum

Sep 30, 2020

$ 279.32M

Maximum

Mar 31, 2024

$ 154.55M

Average

$ 149.16M

Median

Inv. Capital Benchmark Analysis

The chart above depicts the distribution of Inv. Capital for companies in the Total Stock Market. The average Inv. Capital of the companies is $ 758.9M with a standard deviation of $ 1B.
The following table provides additional summary stats:
Inv. Capital in the Market:
filtered constituents3.44K
min$ -1.51B
max$ 4.11B
average$ 758.9M
median$ 302.53M
std$ 1B